Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/Sales ratio is N/A as of 2026-10-06T19:17:35.336Z.
Calculation as of: 2026-10-06T19:17:35.336Z.
Quote observation: 2026-10-06T19:10:13.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4f522eee919378f7ead273ce64f9b652ac6d8ba1380de8c5eb79fdcf7ed4dc2a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
N/A
Market Cap
$30.98M
EV/Sales Ratio
0.50x
TTM Avg
0.48x
3Y Avg
0.60x
5Y Avg
0.58x
Market Cap
$30.06M
EV/Sales Ratio
N/A
TTM Avg
70.91x
3Y Avg
45.25x
5Y Avg
208.18x
Market Cap
$31.44M
EV/Sales Ratio
0.38x
TTM Avg
0.41x
3Y Avg
0.37x
5Y Avg
0.39x
Market Cap
$29.49M
EV/Sales Ratio
186.61x
TTM Avg
271.96x
3Y Avg
271.96x
5Y Avg
271.96x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MDxHealth S.A. (MDXH) | $30.67M | N/A | N/A | N/A | N/A |
| SCYNEXIS, Inc. (SCYX)vs › | $30.63M | 1.15x | 4.69x | 4.99x | 8.32x |
| CervoMed Inc. (CRVO)vs › | $30.46M | 24.80x | 97.17x | 97.17x | 97.17x |
| Rockwell Medical, Inc. (RMTI)vs › | $30.98M | 0.50x | 0.48x | 0.60x | 0.58x |
| BeyondSpring Inc. (BYSI)vs › | $30.06M | N/A | 70.91x | 45.25x | 208.18x |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.05M | N/A | N/A | N/A | N/A |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 0.38x | 0.41x | 0.37x | 0.39x |
| Context Therapeutics Inc. (CNTX)vs › | $29.85M | N/A | N/A | N/A | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.49M | 186.61x | 271.96x | 271.96x | 271.96x |
| Quantum Cyber N.V. (QUCY)vs › | $29.71M | 65.92x | 29.75x | 29.75x | 29.75x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute